08/06/2015 - 1:34pm

Aurobindo Pharma Limited on Tuesday received approval from the Food and Drug Administration for its alprazolam tablets, a generic version of Xanax. 

08/06/2015 - 12:47pm

Mylan on Wednesday announced the U.S. launch of its generic version of Nexium (esomeprazole magnesium delayed-release capsules) in 20- and 40-mg dosage strengths.

08/05/2015 - 10:51am
Par Pharmaceutical announced Wednesday that the Food and Drug Administration had granted final approval of the company’s generic version of Sodium Edecrin (ethacrynate sodium) for injection.
08/04/2015 - 12:43pm

More than 28% of those surveyed fill 20 or more prescriptions per year but only half of those know about prescription savings cards. 

08/03/2015 - 3:34pm

The National Association of Boards of Pharmacy last week released a progress report urging state and federal regulation for the thousands of websites that illegally distribute medications.

07/31/2015 - 2:13pm

Teva Pharmaceutical Industries on Friday announced that it entered commitment letters relating to its upcoming acquisition of Allergan's generic pharmaceuticals business.

07/31/2015 - 2:06pm

In late July, the Government Accountability Office released a report on how the lack of effective communications between the Drug Enforcement Agency and both pharmaceutical distributors and chain pharmacy headquarters has impacted legitimate access to pain medicines. "The agency’s report further validates the need for bipartisan, bicameral legislation," according to NACDS.

07/30/2015 - 3:24pm

Par Pharmaceutical Thursday announced that it has begun shipping the authorized generic version of Megace ES (megestrol acetate, USP) oral suspension.

07/30/2015 - 12:28pm

McKesson on Thursday reported increased revenues for the first quarter, which ended June 30. At $47.5 billion, revenues were up 9%, compared with $43.5 billion a year ago. First-quarter earnings per diluted share from continuing operations was $2.50 compared with $1.76 a year ago.